SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001876512-23-000002
Filing Date
2023-12-01
Accepted
2023-12-01 10:29:32
Documents
1
Effectiveness Date
2023-12-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9263
  Complete submission text file 0001876512-23-000002.txt   10713
Mailing Address 3200 CHERRY CREEK DRIVE SOUTH SUITE 410 DENVER CO 80209
Business Address 3200 CHERRY CREEK DRIVE SOUTH SUITE 410 DENVER CO 80209 8558487627
Vitro Biopharma, Inc. (Filer) CIK: 0000793171 (see all company filings)

IRS No.: 841012042 | State of Incorp.: NV | Fiscal Year End: 1031
Type: D | Act: 33 | File No.: 021-498570 | Film No.: 231457921
SIC: 2836 Biological Products, (No Diagnostic Substances)